You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Merck
Medtronic
Harvard Business School
Johnson and Johnson
AstraZeneca

Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Patent: 8,691,852

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,691,852
Title:Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors
Abstract: The present disclosure relates to compounds of formula (I): ##STR00001## or a pharmaceutically acceptable salt or N-oxide thereof. The present disclosure also relates to pharmaceutical compositions comprising the compounds of formula (I), and to their methods of use in therapy.
Inventor(s): Castro Palomino Laria; Julio Cesar (Barcelona, ES), Erra Sola; Montserrat (Barcelona, ES), Lozoya Toribio; Maria Estrella (Barcelona, ES), Navarro Romero; Eloisa (Barcelona, ES)
Assignee: Amirall, S.A. (Barcelona, ES)
Application Number:13/567,437
Patent Claims:see list of patent claims

Details for Patent 8,691,852

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 002 2017-06-22   Start Trial Amirall, S.A. (Barcelona, ES) 2026-12-22 RX Orphan search
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 001 2017-06-22   Start Trial Amirall, S.A. (Barcelona, ES) 2026-12-22 RX Orphan search
Genentech Inc OCREVUS ocrelizumab INJECTABLE;INJECTION 761053 001 2017-03-28   Start Trial Amirall, S.A. (Barcelona, ES) 2026-12-22 RX search
Janssen Biotech SIMPONI ARIA golimumab INJECTABLE; INJECTION 125433 001 2013-07-18   Start Trial Amirall, S.A. (Barcelona, ES) 2026-12-22 RX search
Novartis ARZERRA ofatumumab INJECTABLE; INJECTION 125326 001 2009-10-26   Start Trial Amirall, S.A. (Barcelona, ES) 2026-12-22 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Harvard Business School
Express Scripts
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.